Looking to publish in Inflammatory Bowel Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginInflammatory Bowel Diseases publishes original basic science, translational, and clinical research regarding pathogenesis, epidemiology, evaluation, and treatment of IBD that will lead to advancements in overall clinical care.
Looking to publish in Inflammatory Bowel Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Inflammatory Bowel Diseases accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Original Articles
Brief Reports
Letters To The Editor
Clinical Practice Guidelines
Recent Publications
Classifications of rheumatological extraintestinal manifestations in inflammatory bowel disease: Unmet needs in clinical practice and trials
Olga Maria Nardone, Yuhong Yuan, Francesco Caso, Janet Pope, Dennis McGonagle, Vipul Jairath
Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study
Nalan Gülşen Ünal, Oğuz Kağan Bakkaloğlu, Taylan Kav, Tuğçe Eşkazan, Haluk Tarık Kani, Atilla Akpınar, Pırıl Akıncıoğlu, Gizem Dağcı, İbrahim Şendur, İlker Büyüktorun, Sezgin Barutçu, Güner Kılıç, Göksel Bengi, Bilger Çavuş, Nevin Oruç, Yeşim Özen Alahdab, Özlen Atuğ, Dinç Dinçer, Tarkan Karakan, Ali İbrahim Hatemi, Yusuf Ziya Erzin, Ahmet Tezel, Murat Törüner, Filiz Akyüz, Aykut Ferhat Çelik
Increased risk of respiratory syncytial virus infection in patients with active inflammatory bowel disease: a matched cohort study
Mohamed H Eldesouki, Youssef Hafez, Ahmed E Salem, Mohammad Alomari, Jana G Hashash, Francis A Farraye
Appendicectomy in ulcerative colitis: a narrative review of epidemiology, pathophysiology, and emerging therapeutic implications
M Juwanwarnage Nuwanthi Rashika Vanojan, Oluwalanoayo Oluwadara Agbabiaka, Devya Kumaresan, Shuker Yahia
Artificial intelligence assessment of endoscopic severity and extent: A machine learning approach to continuous evaluation of endoscopic inflammation in ulcerative colitis
Alvin T George, Klaus Gottlieb, Daniel R Colucci, William J Eastman, Shrujal Baxi, Chakib Battioui, Julian Lehrer, Evan Yu, Pavel Brodskiy, Yeli Wang, Darren Thomason, Mohammad Haft-Javaherian, David T Rubin
Frequently asked questions
How long does it take to publish?
Appeals may take a minimum of 3 to 6 weeks to receive a response from the Editors. Proof corrections must be returned within 48 hours of receipt.
Reformat to Inflammatory Bowel Diseases using Livewrite PremiumIs a cover letter required?
Cover letters are mentioned for disclosure when sharing prior IBD reviews with another journal. Manuscripts posted to a preprint server must be disclosed during submission. AI use should be disclosed in cover letters to editors and in the Methods or Acknowledgements section.
Reformat to Inflammatory Bowel Diseases using Livewrite PremiumWhat are the publication costs?
Subscription journal with open access publishing options available.
Reformat to Inflammatory Bowel Diseases using Livewrite Premium